Drug
teclistamab-cqyv
Marketed as TECVAYLI.
Generic name
teclistamab-cqyv
Brand names
TECVAYLI
First FDA approval
2022-10-25
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761291 | TECVAYLI | 2022-10-25 | JANSSEN BIOTECH |
Manufacturers
JANSSEN BIOTECH
Frequently asked questions
When was teclistamab-cqyv FDA approved?
Earliest FDA approval on record: 2022-10-25.
What brand names are sold as teclistamab-cqyv?
TECVAYLI.
Sources
Appeal a teclistamab-cqyv denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com